CyberKnife® Prostate Cancer Treatment Hero

CyberKnife® Prostate Cancer Treatment

The CyberKnife® Robotic Radiosurgery System was cleared by the U.S. Food and Drug Administration in 2001 to treat tumors anywhere in the body, including the prostate. Despite its name, the CyberKnife System does not involve a surgical procedure. In fact, there is no cutting involved. Instead, the CyberKnife System at Saint Peter’s delivers high doses of radiation directly to the prostate in four to five sessions in a treatment called prostate stereotactic body radiotherapy (SBRT), also referred to as prostate radiosurgery.

The challenge that doctors face in treating prostate tumors with radiation therapy is that the prostate moves unpredictably as air passes through the rectum and as the bladder empties and fills. The CyberKnife System utilizes real-time image guidance to accurately and continuously target the prostate, which often moves during treatment, automatically adjusting to this movement. During treatment, a patient lays still and breathes normally while the CyberKnife zeroes in on a moving target – the prostate – and irradiates it without harming surrounding areas. As a result, the procedure is more comfortable for patients and radiation is delivered more accurately.
Cyberknife is an excellent treatment for the use of low-grade, low-stage prostate cancer, in other words, cancer that is localized to the prostate and has not spread. CyberKnife is a high tech version of traditional radiation.  

Need a second opinion for prostate cancer treatment? 

Our experienced prostate cancer team helps men weigh the pros and cons of the latest prostate cancer treatment options. The main goal of Saint Peter's second opinion consultation is to ensure that prostate cancer patients get what they need, when they need it. To request a second opinion, call our patient navigator at (732) 745-6685. 

CyberKnife at Saint Peter’s offers patients a minimally invasive, alternative prostate cancer treatment. Prostate cancer treatments with CyberKnife are typically performed on an outpatient basis over a period of four to five days, requiring no overnight hospital stays. Most patients experience a quick recovery with minimal to no side effects.  

Still have questions about CyberKnife? Contact our prostate cancer team

New call-to-action

Subscribe to Our Newsletter

Subscribe to the Saint Peter's Better Health newsletter and receive the latest health news, community events, recipes, and more.

Support Saint Peter’s

Your gift of any size directly impacts the patients who are cared for at Saint Peter's. Donate TodayLearn More